- Home
- ONB vs CORT Comparison
ONB vs CORT Comparison
Compare ONB & CORT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONB
- CORT
- Stock Information
- Founded
- ONB 1834
- CORT 1998
- Country
- ONB United States
- CORT United States
- Employees
- ONB N/A
- CORT N/A
- Industry
- ONB Major Banks
- CORT Biotechnology: Pharmaceutical Preparations
- Sector
- ONB Finance
- CORT Health Care
- Exchange
- ONB Nasdaq
- CORT Nasdaq
- Market Cap
- ONB 7.9B
- CORT 7.1B
- IPO Year
- ONB N/A
- CORT N/A
- Fundamental
- Price
- ONB $20.61
- CORT $78.69
- Analyst Decision
- ONB Buy
- CORT Strong Buy
- Analyst Count
- ONB 9
- CORT 4
- Target Price
- ONB $26.11
- CORT $142.00
- AVG Volume (30 Days)
- ONB 3.3M
- CORT 1.1M
- Earning Date
- ONB 04-22-2025
- CORT 05-05-2025
- Dividend Yield
- ONB 2.71%
- CORT N/A
- EPS Growth
- ONB N/A
- CORT 8.36
- EPS
- ONB 1.72
- CORT 1.14
- Revenue
- ONB $1,795,802,000.00
- CORT $685,446,000.00
- Revenue This Year
- ONB $44.42
- CORT $35.85
- Revenue Next Year
- ONB $16.19
- CORT $35.22
- P/E Ratio
- ONB $12.04
- CORT $68.97
- Revenue Growth
- ONB 3.29
- CORT 30.93
- 52 Week Low
- ONB $15.60
- CORT $27.30
- 52 Week High
- ONB $24.49
- CORT $117.33
- Technical
- Relative Strength Index (RSI)
- ONB 43.60
- CORT 62.98
- Support Level
- ONB $21.30
- CORT $74.34
- Resistance Level
- ONB $22.70
- CORT $75.50
- Average True Range (ATR)
- ONB 0.43
- CORT 3.21
- MACD
- ONB -0.16
- CORT 0.50
- Stochastic Oscillator
- ONB 17.39
- CORT 92.19
About ONB Old National Bancorp
Old National Bancorp with almost $10 billion in assets following its latest acquisition, Old National Bancorp is a financial services bank holding company headquartered in Indiana. Based in Evansville, Ind., Old National owns multiple financial services operations in Indiana, Illinois, and Kentucky. The company provides a group of similar community banking services, including such products and services as commercial, real estate, and consumer loans; deposits; and brokerage, trust, and investment advisory services.
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol.